7-Year survival results of perioperative chemotherapy with Epidoxorubicin, Etoposide, and Cisplatin (EEP) in locally advanced resectable gastric cancer: Up-to-date analysis of a phase-II study

Annals of Surgical Oncology

Volumn 15, Issue 8, 2008, Pages 2146-2152

  Persiani, Roberto ^a   Rausei, Stefano ^a   Pozzo, Carmelo ^a   Biondi, Alberto ^a   Barone, Carlo ^a   Cananzi, Ferdinando C M ^a   Schinzari, Giovanni ^a   D'Ugo, Domenico ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

EEP chemotherapy; Locally advanced gastric cancer; Pathologic response; Preoperative chemotherapy

Indexed keywords

CISPLATIN; EPIRUBICIN; ETOPOSIDE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BIOPSY; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CHI SQUARE TEST; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LOCALLY ADVANCED GASTRIC CANCER; LOG RANK TEST; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PERIOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH CANCER; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FEMALE; GASTRECTOMY; GLUCURONATES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERIOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 48149111683     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9982-2     Document Type: Article

References (28)

1. T Kobayashi T Kimura 2000 Long-term outcome of preoperative chemotherapy with 5′-deoxy-5-fluorouridine (5′-DFUR) for gastric cancer Jpn J Cancer Chemother 27 1521 6
2. CP Schuhmacher U Fink K Becker 2001 Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up Cancer 91 918 27
3. SG Marcus D Cohen K Lin 2003 Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer J Gastrointest Surg 7 1015 22
4. HH Hartgrink CJH van deVelde H Putter 2004 Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial INCLUDE Eur J Surg Oncol 30 643 9
5. Y Nio M Koike H Omori 2004 A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer-a single institute study Anticancer Res 24 1879 87
6. Wu AW, Xu GW, Wang HY, et al. Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005047. doi: 10.1002/14651858.CD005047.pub3
7. D Cunningham WH Allum SP Stenning 2006 MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
8. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 5
9. C Barone A Cassano C Pozzo 2004 Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer Oncology 67 48 53
10. A Picciocchi DM D'Ugo P Ronconi 1997 The impact of staging laparoscopy on the treatment of locally advanced gastric cancer J Exp Clin Cancer Res 16 84 6
11. C Barone DC Corsi C Pozzo 1998 Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies Cancer 82 1460 7
12. World Health Organisation: "Handbook for Reporting Results for Cancer Treatment." Geneva: WHO, 1979
13. Japanese Research Committee for Gastric Cancer 1981 The general rules for gastric cancer study in surgery and pathology Jpn J Surg 11 127 38
14. Sobin LH, Wittekind C. "TNM classification of malignant tumors, 6th edition." New York: John Wiley & Sons, 2002
15. K Becker U Fumagalli JD Mueller 1999 Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes Cancer 85 1484 9
16. JR Siewert K Böttcher HJ Stein 1998 Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study Ann Surg 228 449 61
17. JA Ajani DM Ota DE Jackson 1991 Current strategies in the management of locoregional and metastatic gastric carcinoma Cancer 67 Suppl 1 260 5
18. P Preusser H Wilke W Achterrath 1989 Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer J Clin Oncol 7 1310 7
19. E Bajetta M Di Bartolomeo F de Braud 1994 Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group Eur J Cancer 30A 596 600
20. E Diaz-Rubio J Jimeno E Aranda 1992 Etoposide (E) + epirubicin (E) + cisplatin (P) combination chemotherapy (EEP) in advanced gastric cancer: negative impact on clinical outcome. Spanish Cooperative Group for GI Tumor Therapy (T.T.D.) Ann Oncol 3 861 3
21. JL Clark O Kucuk DS Neuberg 1995 Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study Am J Clin Oncol 18 318 24
22. D D'Ugo R Persiani S Rausei 2006 Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer Eur J Surg Oncol 32 1105 9
23. Y Yonemura K Kinoshita T Fujimura 1996 Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients Hepatogastroenterology 43 1260 72
24. AM Lowy PF Mansfield SD Leach 1999 Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer Ann Surg 229 303 8
25. K Becker JD Mueller C Schuhmacher 2003 Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy Cancer 98 1521 30
26. R Persiani D D'Ugo S Rausei 2005 Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy J Surg Oncol 89 227 36
27. L Lim M Michael GB Mann 2005 Adjuvant therapy in gastric cancer J Clin Oncol 23 6220 32
28. J Sastre JA Garcia-Saenz E Diaz-Rubio 2006 Chemotherapy for gastric cancer World J Gastroenterol 12 204 13